PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryFeb 5, 2003	Integra LifeSciences Announces CE Mark for the NeuraGenT Nerve Guide for Repair of Severed Peripheral Nerves Integra LifeSciences Announces CE Mark for the NeuraGenT Nerve Guide for Repair of Severed Peripheral Nerves Plainsboro, New Jersey, February 5, 2003-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received the CE mark for the NeuraGenT Nerve Guide, an	View HTML Integra LifeSciences Announces CE Mark for the NeuraGenT Nerve Guide for Repair of Severed Peripheral Nerves 12.5 KB
Toggle SummaryOct 18, 2004	Integra LifeSciences Announces CE Mark for DuraGen Plus Adhesion Barrier Matrix Integra LifeSciences Announces CE Mark for DuraGen Plus(TM) Adhesion Barrier Matrix PLAINSBORO, N.J., Oct. 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received CE Mark Certification for the DuraGen Plus™ Adhesion Barrier Matrix.	View HTML Integra LifeSciences Announces CE Mark for DuraGen Plus(TM) Adhesion Barrier Matrix 12.2 KB
Toggle SummaryJun 26, 2013	Integra LifeSciences Announces CE Mark and European Launch of Integra(R) Smart Cervical Solution PLAINSBORO, N.J., June 26, 2013 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has received European CE Mark for its Integra ® Smart Cervical Solution, a device approved in the European Union for treating degenerative diseases of the cervical	View HTML Integra LifeSciences Announces CE Mark and European Launch of Integra(R) Smart Cervical Solution 12.7 KB
Toggle SummaryApr 4, 2014	Integra LifeSciences Announces Camino(R) Flex Ventricular Catheter Receives FDA Clearance for Use With MRI Scans PLAINSBORO, N.J., April 4, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Camino® Flex Ventricular Catheter has received clearance from the United States Food and Drug Administration (FDA) for use with magnetic resonance imaging (MRI).	View HTML Integra LifeSciences Announces Camino(R) Flex Ventricular Catheter Receives FDA Clearance for Use With MRI Scans 12.7 KB
Toggle SummaryDec 22, 2016	Integra LifeSciences Announces Approval of Two-for-One Stock Split PLAINSBORO, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that its stockholders approved a two-for-one stock split and an increase from 60 million to 240 million authorized shares of the Company's common stock at a special meeting of	View HTML Integra LifeSciences Announces Approval of Two-for-One Stock Split 11.1 KB
Toggle SummaryDec 21, 2011	Integra LifeSciences Announces Appointment of Peter Arduini as President and Chief Executive Officer; Stuart Essig Named Chairman of the Board PLAINSBORO, N.J., Dec. 21, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that its Board of Directors has made the following changes, all effective January 3, 2012. The Board appointed Peter Arduini as President and Chief Executive Officer. In	View HTML Integra LifeSciences Announces Appointment of Peter Arduini as President and Chief Executive Officer; Stuart Essig Named Chairman of the Board 12.4 KB
Toggle SummaryJul 31, 2006	Integra LifeSciences Announces Amendment to Exchange Offer for Its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 Integra LifeSciences Announces Amendment to Exchange Offer for Its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 PLAINSBORO, N.J., Jul 31, 2006 (PRIMEZONE via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has modified its	View HTML Integra LifeSciences Announces Amendment to Exchange Offer for Its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 12.7 KB
Toggle SummaryAug 28, 2006	Integra LifeSciences Announces Amendment to Exchange Offer for Its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 Integra LifeSciences Announces Amendment to Exchange Offer for Its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 PLAINSBORO, N.J., Aug. 28, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has extended the expiration date and	View HTML Integra LifeSciences Announces Amendment to Exchange Offer for Its 2-1/2 Percent Contingent Convertible Subordinated Notes Due 2008 13.2 KB
Toggle SummaryAug 14, 2006	Integra LifeSciences Announces Amendment to Exchange Offer for its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008 Integra LifeSciences Announces Amendment to Exchange Offer for its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008 PLAINSBORO, N.J., Aug. 14, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it has waived a condition and extended the	View HTML Integra LifeSciences Announces Amendment to Exchange Offer for its 2 1/2 Percent Contingent Convertible Subordinated Notes Due 2008 12.4 KB
Toggle SummaryMay 7, 2018	Integra LifeSciences Announces Amendment and Extension of Credit Facility PLAINSBORO, N.J. , May 07, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it has amended and extended its credit facility with a bank group led by Bank of America, N.A.	View HTML PDF Version